Hongjian Shen

Hongjian Shen

Auto-generated profile, based on publicly available information

Hongjian Shen

Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
PXPengfei Xing
Pengfei Xing
PYP.F. Yang
P.F. Yang
ZLZ.F. Li
Z.F. Li
LZLei Zhang
Lei Zhang
HSH.J. Shen
H.J. Shen
JLJian-Min Liu
Jian-Min Liu
BACKGROUND AND PURPOSE: There is no consensus on endovascular treatment for terminal ICA. The purpose of this study was to evaluate the comparative safety and efficacy of preferred aspiration thrombectomy and stent retriever thrombectomy for revascularization in patients with isolated terminal ICA occlusion. MATERIALS AND METHODS: We conducted a retrospective analysis of patients with terminal ICA occlusion treated with aspiration thrombectomy or stent retriever thrombectomy in our center, from September 2013 to November 2018. To minimize the case bias, propensity score matching was performed. The primary outcomes were successful reperfusion defined by expanded TICI grades 2b–3 at the end of all endovascular procedures and puncture-to-reperfusion time. RESULTS: A total of 109 consecutive patients with terminal ICA occlusion were divided into the aspiration thrombectomy group (40 patients) and the stent retriever thrombectomy group (69 patients), and 30 patients were included in each group after propensity score matching. The proportion of complete reperfusion was significantly higher in the aspiration thrombectomy group (OR 4.75 [95% CI, 1.10–1.38]; P = .002). The median puncture-to-reperfusion time in the aspiration thrombectomy group was shorter than that in the stent retriever thrombectomy group (38 versus 69 minutes; P = .001). Fewer intracerebral hemorrhage events were recorded in the aspiration thrombectomy group (OR 0.29 [95% CI, 0.09–0.90]; P = .028). No significant differences were observed for good outcomes (OR 1.92 [95% CI, 0.86–4.25]) and mortality (OR 0.84 [95% CI, 0.29–2.44]) at 90 days. CONCLUSIONS: For the treatment of terminal ICA occlusion, aspiration thrombectomy was technically superior to stent retriever thrombectomy in the absence of a balloon guide catheter in achieving successful reperfusion with shorter puncture-to-reperfusion time and procedure-related adverse events.

1 April 2020 in Clinical Neuroradiology
Verified
Journal Article
Closed access
PDF file
WYWenjin Yang
Wenjin Yang
YZYongxin Zhang
Yongxin Zhang
ZLZifu Li
Zifu Li
LZLei Zhang
Lei Zhang
HLHe Li
He Li
JLJian-Min Liu
Jian-Min Liu

5 November 2021 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
WYWenjin Yang
Wenjin Yang
LZLei Zhang
Lei Zhang
ZLZifu Li
Zifu Li
YZYongxin Zhang
Yongxin Zhang
HLHe Li
He Li
PYPengfei Yang
Pengfei Yang

30 May 2026 in International Journal of Stroke
Verified
Journal Article
Closed access
HSHongjian Shen
Hongjian Shen
PYPengfei Yang
Pengfei Yang
LSLili Song
Lili Song
YZYongwei Zhang
Yongwei Zhang
XZXiaoxi Zhang
Xiaoxi Zhang
JLJianmin Liu
Jianmin Liu
Background: High-quality randomized controlled trials (RCTs) have extended the endovascular therapy (EVT) time window to 24 h post-stroke onset in selected patients with acute ischemic stroke (AIS). Recent retrospective studies indicate that EVT performed beyond 24 h may still improve clinical outcomes. However, the specific benefit–risk profile in this ultra-late window remains unclear. Aim: The trial is designed to address this evidence gap and determine the benefit–risk balance of EVT in the ultra-late window. Methods and design: The Large Artery occlusion Treated in Extended Time with Mechanical Thrombectomy (LATE-MT) is an investigator-initiated, multicenter, prospective, randomized, open, blinded-endpoint assessment (PROBE) clinical trial. The trial adopted an adaptive group-sequential design, recruiting 336 AIS patients with large-vessel occlusion within 24–72 h of the last known well across 35 stroke centers in China. Eligible subjects who meet both clinical and imaging selection criteria are randomized 1:1 to EVT or medical management. Outcomes: The primary outcome is an ordinal shift analysis of scores on the modified Rankin scale (mRS) at 90 days. Key secondary outcomes include neurological function at 24 h and 7 days, death/major disability, and utility-weighted mRS (UW-mRS) at 90 days. Safety outcomes include any intracranial hemorrhage (ICH), symptomatic ICH, serious adverse event, and all procedural complications.

6 March 2024 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
HLHuangbin Lin
Huangbin Lin
HSHongjian Shen
Hongjian Shen
NWNuo Wang
Nuo Wang
TWTao Wu
Tao Wu

28 April 2023 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
WYWenjin Yang
Wenjin Yang
YFYi-Bin Fang
Yi-Bin Fang
LZLei Zhang
Lei Zhang
ZLZifu Li
Zifu Li
PXPengfei Xing
Pengfei Xing
PYPengfei Yang
Pengfei Yang